Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nan Fung Life Sciences and affiliate Pivotal BioVenture Partners invested in the ophthalmology therapy developer having incubated it last year.

New investor Lilly Asia Ventures helped the cancer testing kit provider increase its overall funding to more than $160m.

Marie-Laure Mahé is heading up the recently launched corporate venture capital subsidiary of health and hygeine product maker Essity.

The GSK, Amgen and Novo-backed cancer drug developer went public in an upsized offering priced above its range.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Neil Woodford has reportedly joined former WIM chief executive Craig Newman at Juno Capital to form a portfolio of unquoted healthcare stocks.

MIT-founded biochemical water treatment company Solugen has increased its funding total to at least $48.7m.

The second quarter total is up from $185m the previous year and $392m quarter-on-quarter despite coronavirus-driven pressures.

Primary care network Oak Street Health has filed for a $100m offering on the New York Stock Exchange that will give Humana an exit.